Latest Breaking News On - Graphene compound - Page 1 : comparemela.com

Zentek Files Amended and Restated Financial Statements and MD&A, Provides Year End Update on Key Projects and Initiatives, and Amends Terms of Proposed Financing

Zentek Files Amended and Restated Financial Statements and MD&A, Provides Year End Update on Key Projects and Initiatives, and Amends Terms of Proposed Financing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBritish columbiaMohammad arjmandBaicheng chenTony mazzulliMatt blazeiYingfu liDeepak sridharDeutsches zentrumLukas bichlerAntony thiruppathiJohn brennanGeorge zhanelSeyyedarash haddadiConsultants canada ltd

Zentek Ltd : Zentek Files Amended and Restated Financial Statements and MD&A, Provides Year End Update on Key Projects and Initiatives, and Amends Terms of Proposed Financing

Guelph, Ontario (Newsfile Corp. - December 23, 2021) - Zentek Ltd. (TSXV: ZEN) (OTC: ZENYF) ("ZEN" or the "Company"), a Canadian IP development and commercialization company focused on next-gen healthcare

United statesUnited kingdomBritish columbiaMohammad arjmandBaicheng chenTony mazzulliMatt blazeiYingfu liDeepak sridharDeutsches zentrumLukas bichlerAntony thiruppathiJohn brennanGeorge zhanelSeyyedarash haddadiConsultants canada ltd

Zentek Files Amended and Restated Financial Statements and MD&A, Provides Year End Update on Key Projects and Initiatives, and Amends Terms of Proposed Financing

ZEN Graphene Solutions Develops Novel Graphene-Based Potential Treatment for Bacterial and Viral Infections in Humans

ZEN Graphene Solutions Develops Novel Graphene-Based Potential Treatment for Bacterial and Viral Infections in Humans Zen Graphene Solutions Ltd. is pleased to announce that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound. Recently received testing results from the University Health NetworkMount Sinai Hospital Department of Microbiology in Toronto indicate that this patent pending formulation could be a medical breakthrough in the treatment of numerous human-contracted pathogens including, … Zen Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) (“ZEN” or the “Company”) is pleased to announce that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound. Recently received testing results from the University Health NetworkMount Sinai Hospital Department of Microbiology in Toronto indicate that this patent pending formulation could be a medical breakthrough in the treatment of numerous human-contr

United statesUnited kingdomGreg fentonCandida albicansTony mazzulliFrancis dubeUniversity of torontoHealth canadaDepartments of laboratory medicine pathobiologyVenture exchangeRegulation services providerZen graphene solutions ltdZen graphene solutionsInfectious disease specialistMount sinaiLaboratory medicine

ZEN Graphene Solutions Ltd : ZEN Graphene Solutions Develops Novel Graphene-Based Potential Treatment for Bacterial and Viral Infections in Humans

ZEN Graphene Solutions Ltd.: ZEN Graphene Solutions Develops Novel Graphene-Based Potential Treatment for Bacterial and Viral Infections in Humans ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ( ZEN or the Company ) is pleased to announce that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound. Recently received testing results from the University Health Network/Mount Sinai Hospital Department of Microbiology in Toronto indicate that this patent pending formulation could be a medical breakthrough in the treatment of numerous human-contracted pathogens including, upper and lower respiratory tract infections - where COVID-19 is a major contributor - as well as drug resistant organisms. Testing was conducted by Dr. Tony Mazzulli, MD, FRCPC, FACP, Microbiologist-in-Chief & Infectious Disease Specialist at Mount Sinai Hospital. Dr. Mazzulli is also a Professor at the Departments of Laboratory Medicine & Pathobiology and Medicine

United statesUnited kingdomGreg fentonCandida albicansTony mazzulliFrancis dubeGraphene solutions ltdUniversity of torontoNewsfile corpDepartments of laboratory medicine pathobiologyHealth canadaRegulation services providerVenture exchangeUniversity healthMount sinai hospital departmentInfectious disease specialist